title: Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA. mmazepa@unch.unc.edu.
authors.forename: Marshall A
authors.initials: MA
authors.lastname: Mazepa
authors.forename: Jay S
authors.initials: JS
authors.lastname: Raval
authors.forename: Stephan
authors.initials: S
authors.lastname: Moll
authors.forename: Alice
authors.initials: A
authors.lastname: Ma
authors.forename: Yara A
authors.initials: YA
authors.lastname: Park
mesh_terms: D051722:ADAM Proteins / Q000037:antagonists & inhibitors / Q000276:immunology*; D000071120:ADAMTS13 Protein; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001323:Autoantibodies / Q000276:immunology* / Q000378:metabolism; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D008875:Middle Aged; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D011719:Pyrazines / Q000627:therapeutic use*; D012008:Recurrence; D012074:Remission Induction
chemical_list: D000970:Antineoplastic Agents; D001323:Autoantibodies; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human
keywords: bortezomib; thrombotic haemolytic anaemias; thrombotic thrombocytopenic purpura